Astellas Uses Boltz for Protein Target Research
HannesStaerk · x · 2026-07-16
Astellas has publicly shared how they used Boltz to research a membrane protein target: the team identified validated molecules that performed comparably to clinical candidates in in vitro experiments.
The highlight of this case is efficiency: the number of required experiments reportedly dropped by 90%, and the overall timeline was shortened by 70%. This serves as a clear AI for Science use case.
More from Research
- π0.5 study: raising demos from 10 to 438 lifts Place Ball in Bowl success from 7% to 83% — stingning · 2026-10-27
- HandsOn benchmark: 66 verified tasks and 18,000 human demos for dexterous manipulation — stingning · 2026-10-27
- HandsOn benchmark: 66 human-verified tasks and 18,000 curated demos for dexterous manipulation — stingning · 2026-10-27
- HandsOn splits evaluation: Core-50 execution vs Transfer-16 zero-demo transfer — stingning · 2026-10-27
- FrontierCS 2 launches on Kaggle: 48 tasks make agents beat published CS papers — MeganRisdal · 2026-10-27
- LightMTP: lightweight latent multi-token prediction boosts LLM planning in pretraining — gdm3000 · 2026-10-27